Mauricio Garcia Saenz de Sicilia

Associate Professor

Last publication 2025 Last refreshed 2026-05-16

faculty

Internal Med, College of Medicine

2 h-index 10 pubs 8 cited

Biography and Research Information

OverviewAI-generated summary

Dr. Mauricio Garcia Saenz de Sicilia's research focuses on liver disease and transplantation, with a particular interest in factors influencing patient outcomes. He has investigated disparities in liver transplantation, examining how socioeconomic status affects women's likelihood of receiving a transplant. His work also addresses the prediction of esophageal varices in patients with advanced chronic liver disease and explores the complex relationship between non-alcoholic fatty liver disease and drug-induced liver injury within a metabolic context. Dr. Garcia completed his fellowship in advanced transplant hepatology at the University of Nebraska and holds board certification in internal medicine and gastroenterology. He has contributed to the field through publications and scholarly activity, with recent work published in 2025.

Research Overview

Dr. Mauricio Garcia joined the Division of Gastroenterology and Hepatology in the UAMS Department of Internal Medicine after completing an advanced fellowship in advanced transplant hepatology at the University of Nebraska. He received his medical degree from the University of National Autonomy of Mexico and completed his residency in internal medicine and a fellowship in gastroenterology from there as well. He is board certified in internal medicine and gastroenterology.

Metrics

  • h-index: 2
  • Publications: 10
  • Citations: 8

Selected Publications

  • The role of artificial intelligence in gastroenterology: current perspectives and future directions—narrative review (2026)
  • Predicting Esophageal Varices and Varices Needing Treatment in Compensated Advanced Chronic Liver Disease (2025)
    3 citations DOI OpenAlex
  • A Systematic Review and Meta-Analysis of Liver Transplant Outcomes in Lean Versus Non-Lean Metabolic Dysfunction-Associated Steatotic Liver Disease Patients (2025)
  • Non-alcoholic fatty liver disease and drug induced liver injury: A metabolic storm waiting to happen (2025)
  • S4862 Multifaceted Diagnostic Approach for Unexplained Anemia in a Post Liver Transplant Patient With Metastatic Adenocarcinoma and Roux-en-Y Gastric Bypass (2024)
  • Women Referred for Liver Transplant Are Less Likely to Be Transplanted Irrespective of Socioeconomic Status (2023)
    4 citations DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

  • 205952 A Phase 2, Double-Blind, Randomized Study Evaluating the Safety, Tolerability, and Efficacy of GS-4997 in Combination with Prednisolone versus Prednisolone Alone in Subjects with Severe Alcoholic Hepatitis (AH) Gilead Sciences, Inc. Principal Investigator
  • No FP attached TARGET PharmaSolutions Inc Principal Investigator
  • 205952 A Phase 2, Double-Blind, Randomized Study Evaluating the Safety, Tolerability, and Efficacy of GS-4997 in Combination with Prednisolone versus Prednisolone Alone in Subjects with Severe Alcoholic Hepatitis (AH) Gilead Sciences, Inc. Principal Investigator

Collaboration Network

19 Collaborators 5 Institutions 1 Country

Top Collaborators

Similar Researchers

Based on overlapping research topics